Zilberberg, M. D., Kothari, S., & Shorr, A. F. (2009). Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: A model simulation. BioMed Central.
Chicago Style CitationZilberberg, Marya D., Smita Kothari, i Andrew F. Shorr. Cost-effectiveness of Micafungin As an Alternative to Fluconazole Empiric Treatment of Suspected ICU-acquired Candidemia Among Patients With Sepsis: A Model Simulation. BioMed Central, 2009.
Cita MLAZilberberg, Marya D., Smita Kothari, i Andrew F. Shorr. Cost-effectiveness of Micafungin As an Alternative to Fluconazole Empiric Treatment of Suspected ICU-acquired Candidemia Among Patients With Sepsis: A Model Simulation. BioMed Central, 2009.